Many runners find that initial healing gains persist even after stopping BPC-157, consistent with the lasting gene expression changes the peptide induces
A licensed provider can help determine whether oral BPC-157 makes sense for your situation
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
The authors reported that BPC 157 alone (without carrier) ameliorates healing of tendon and bone in the experimental rat model, with macroscopic, microscopic, and biomechanical assessments showing recovery of the tendon-to-bone unit that was not observed in untreated controls [3]